Massive study aims to crack the code of metastatic breast cancer

NCT ID NCT03758976

Recruiting now Knowledge-focused Sponsor: Lund University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is tracking 2,000 people with metastatic breast cancer to understand how the cancer changes over time and in response to treatment. Researchers will analyze tumor and blood samples to find genetic markers that predict which therapies work best. The goal is to develop better tools for personalizing care and overcoming drug resistance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to better ways to predict how metastatic breast cancer will behave and which treatments might work best for each patient.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly help participants. It may take years to produce useful results, and the findings might not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm Neoplastic Cells, Circulating

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC BREAST CANCER

Contacts and locations

Locations

Lund University Hospital
RECRUITING

Lund, 221 85, Sweden
Lund University Hospital
RECRUITING

Lund, 221 85, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.